Skip to main content
. 2019 Mar 31;85(6):1290–1302. doi: 10.1111/bcp.13896

Figure 6.

Figure 6

Oxygen equilibrium curves from blood of a voxelotor‐treated SCD patient compared with a healthy volunteer. Representative predose and 24 h postdose OECs of SCD patients who achieved 23% Hb modification on a single 1000‐mg voxelotor dose, compared with the OEC of a healthy volunteer on placebo